CDSCO Panel grants J&J Protocol Amendment proposal to study anticancer drug Amivantamab and Lazertinib Dr. Divya Colin9 Jan 2024 5:45 PM ISTNew Delhi: Regarding the study of Amivantamab and Lazertinib in combination with platinum-based chemotherapy compared with platinum-based chemotherapy...
AstraZeneca Gets CDSCO Panel Nod to Study anticancer drug Volrustomig Dr. Divya Colin3 Jan 2024 6:00 PM ISTNew Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Submit safety, efficacy data of Indian Patients: CDSCO Panel Tells AstraZeneca on additional indication of Enhertu 100mg Dr. Divya Colin29 Dec 2023 6:15 PM ISTNew Delhi: In response to the drug major AstraZeneca's proposal for the additional indication of Trastuzumab Deruxtecan Powder Concentrate Solution...
Durvalumab safely improves survival in lung cancer patients with limited physical function Dr. Kamal Kant Kohli1 Dec 2023 9:00 AM ISTUSA: A recent study published in eClinicalMedicine has shown single-agent durvalumab to be safe and well tolerated in the first-line treatment of...
Atezolizumab monotherapy bests single-agent chemotherapy among patients with advanced non-small-cell lung cancer Dr. Shravani Dali5 Sept 2023 8:00 PM ISTAtezolizumab monotherapy bests single-agent chemotherapy among patients with advanced non-small-cell lung cancer suggests a new study published in...
Wildfire exposure linked to worse survival among operated patients of non small cell lung cancer: JAMA Jacinthlyn Sylvia31 July 2023 9:45 AM ISTA new study by Danlu Zhang and team found that wildfire exposure was linked to worse overall survival after non-small cell lung cancer (NSCLC)...
Medical Bulletin 27/March/2023 Dr. Nandita Mohan27 March 2023 5:15 PM ISTHere are the top medical news for the day:Study shows Buprenorphine after nonfatal opioid overdose reduces risk of overdose deathReceiving...
Saving more lung tissue in lung cancer surgeries supported in new study Isra Zaman27 March 2023 9:15 AM ISTThe traditional treatment for early-stage non-small cell lung cancer is a lobectomy, where a surgeon eradicates cancerous tissue by removing an entire...
Before surgery immunotherapy plus chemotherapy improves patient outcomes in operable lung cancer: Study Isra Zaman21 March 2023 9:30 AM ISTAmong patients diagnosed with NSCLC, roughly 30% have potentially resectable disease, meaning their tumor can be surgically removed. While many of...
Medical Bulletin 21/March/2023 Isra Zaman21 March 2023 3:15 AM ISTHere are the top medical news for the day:Before surgery immunotherapy plus chemotherapy improves patient outcomes in operable lung cancer: StudyAmong...
Imfinzi plus Imjudo approved in EU for patients with advanced liver and non small cell lung cancers: AstraZeneca Ruchika Sharma25 Feb 2023 10:00 AM ISTUK: AstraZeneca has announced that Imfinzi (durvalumab) and Imjudo (tremelimumab) immunotherapy combinations have been approved in the European Union...
Medical Bulletin 14/February/2023 Isra Zaman14 Feb 2023 4:05 PM ISTHere are the top medical news for the day:MIT and Caltech engineers demonstrate Ingestible sensor that could help doctors pinpoint GI difficultiesGI...
